Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4144368 Title: RÉGIME D'IMMUNISATION CONTRE LE VRS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
221808314
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
4144368
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
26/01/2012
Grant date:
26/02/2025
EP publication date:
08/03/2023
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/02/2025
EP B1 publication date:
26/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
26/01/2032

Applicant

Name:
GlaxoSmithKline Biologicals S.A.
Legal Form:
From:
26/02/2025
Address:
rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)
To:

Agent

Name:
NLO
Legal Form:
From:
10/03/2025
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

Inventor

Name:
DORMITZER, Philip, R.
Legal Form:
Address:
Emeryville, CA 94662-8097, United States (US)

Priority

Priority patent number:
201161436355 P
Priority date:
26/01/2011
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/12; A61P 31/14;

Publication

European Patent Bulletin

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
02/02/2026
Annual fee number:
15
Annual fee amount:
360 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
10/03/2025 General Document Declaration of domicile 2 PDF /9/9/8/3/1/0722513899/docs/221808314_0_generaldocument_20250311_084527387.pdf
10/03/2025 Outgoing Correspondence 1 PDF /9/9/8/3/1/0722513899/docs/221808314_1_outgoingcorrespondence_20250311_084527288.pdf
10/03/2025 Incoming Correspondence (Email) Cover letter 1 PDF /9/9/8/3/1/0722513899/docs/221808314_2_incomingcorrespondenceelectronic_20250311_084527517.pdf
11/03/2025 General Document Other 1 PDF /9/9/8/3/1/0722513899/docs/221808314_3_generaldocument_20250319_112158906.pdf
31/03/2025 Outgoing Correspondence 1 PDF /9/9/8/3/1/0722513899/docs/221808314_4_outgoingcorrespondence_20250401_084553389.pdf
31/03/2025 General Document Declaration of domicile 1 PDF /9/9/8/3/1/0722513899/docs/221808314_5_generaldocument_20250401_084553495.pdf
31/03/2025 Incoming Correspondence (Email) Cover letter 2 PDF /9/9/8/3/1/0722513899/docs/221808314_6_incomingcorrespondenceelectronic_20250401_084553628.pdf